|
|
|
Insider
Information: |
Pomerantz Roger |
Relationship: |
|
City: |
Chalfont |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
323,286 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$289,919 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
323,286 |
|
|
Total
Value |
$289,919 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Seres Therapeutics, Inc. |
MCRB |
President and CEO, Dir... |
2018-09-07 |
213,976 |
2015-06-26 |
0 |
Premium* |
|
Contrafect Corp |
CFRX |
Director |
2017-07-25 |
800 |
2017-07-25 |
0 |
Premium* |
|
Rubius Therapeutics, Inc. |
RUBY |
Director |
2018-07-20 |
100 |
2018-07-20 |
0 |
Premium* |
|
Viracta Therapeutics Ord Shs |
VIRX |
|
2024-05-25 |
108,410 |
2022-02-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2015-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
22,727 |
22,727 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-04-01 |
4 |
AS |
$25.69 |
$2,397,303 |
D/D |
(90,963) |
22,727 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-04-04 |
4 |
AS |
$28.17 |
$1,296,493 |
D/D |
(44,825) |
22,727 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-04-07 |
4 |
AS |
$30.00 |
$276,360 |
D/D |
(9,212) |
22,727 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-05-02 |
4 |
AS |
$28.95 |
$1,270,018 |
D/D |
(43,687) |
22,727 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-05-03 |
4 |
AS |
$27.80 |
$663,179 |
D/D |
(23,680) |
22,727 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-05-04 |
4 |
AS |
$26.52 |
$777,536 |
D/D |
(29,298) |
22,727 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-05-05 |
4 |
AS |
$25.48 |
$772,742 |
D/D |
(30,027) |
22,727 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-05-06 |
4 |
AS |
$24.28 |
$206,803 |
D/D |
(8,507) |
22,727 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-05-24 |
4 |
AS |
$30.00 |
$294,030 |
D/D |
(9,801) |
183,692 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-06-01 |
4 |
AS |
$30.12 |
$2,164,838 |
D/D |
(70,951) |
183,692 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-06-02 |
4 |
AS |
$31.62 |
$2,407,916 |
D/D |
(74,049) |
183,692 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-07-01 |
4 |
AS |
$29.12 |
$1,692,705 |
D/D |
(56,789) |
183,692 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-07-05 |
4 |
AS |
$29.27 |
$1,546,758 |
D/D |
(52,776) |
183,692 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-07-06 |
4 |
AS |
$29.27 |
$1,050,716 |
D/D |
(35,435) |
183,692 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2016-07-27 |
4 |
AS |
$35.00 |
$700,000 |
D/D |
(20,000) |
183,692 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2018-05-09 |
4 |
AS |
$9.00 |
$2,097 |
D/D |
(233) |
324,304 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2018-06-20 |
4 |
AS |
$9.33 |
$247,051 |
D/D |
(26,492) |
297,812 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2018-06-21 |
4 |
AS |
$9.06 |
$172,094 |
D/D |
(18,987) |
278,825 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2018-06-22 |
4 |
AS |
$9.36 |
$374,761 |
D/D |
(40,057) |
238,768 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2018-06-25 |
4 |
AS |
$9.21 |
$246,504 |
D/D |
(26,752) |
228,304 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2018-06-26 |
4 |
AS |
$9.19 |
$195,133 |
D/D |
(21,224) |
228,304 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2018-06-27 |
4 |
AS |
$9.03 |
$153,408 |
D/D |
(16,991) |
228,304 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2018-06-28 |
4 |
AS |
$9.15 |
$197,375 |
D/D |
(21,560) |
228,304 |
0 |
- |
|
MCRB |
Seres Therapeutics, Inc. |
President and CEO |
|
2018-06-29 |
4 |
AS |
$9.10 |
$40,915 |
D/D |
(4,496) |
228,304 |
0 |
- |
|
71 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|